Skip to main content
Renascience Inc. logo

Renascience Inc. — Investor Relations & Filings

Ticker · 4889 ISIN · JP3981100005 T Manufacturing
Open in API
Filings indexed 52 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country JP Japan
Listing T 4889

About Renascience Inc.

https://www.renascience.co.jp/en/

Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on the research and development of various medical modalities, including pharmaceuticals, medical devices, and artificial intelligence (AI) applications. A primary area of its R&D is the study of cellular senescence at the molecular level to develop novel medicines for diseases associated with tissue aging. While initially founded with a focus on kidney disease, Renascience collaborates with academic institutions and corporate partners to advance its diverse R&D pipelines through clinical trials.

Recent filings

Filing Released Lang Actions
定款一部変更のお知らせ
Regulatory Filings Classification · 80% confidence The document is a brief stock exchange announcement notifying investors that the board has resolved to propose a partial amendment to the company’s articles of incorporation at the upcoming ordinary shareholders’ meeting. It does not contain financial statements, proxy materials, or detailed governance policies — it merely reports a board resolution and the proposed amendment text. This fits the catch-all category for miscellaneous regulatory notices rather than a formal report (10-K, IR, AR), dividend notice, proxy statement, or governance code document. Therefore, it should be classified as a general regulatory filing (RNS).
2026-05-25 Japanese
事業計画及び成長可能性に関する事項
Investor Presentation Classification · 90% confidence The document is a lengthy (30K+ characters) multi‐section slide deck describing Renascience’s corporate overview, R&D pipeline, clinical trial plans, growth strategy, KPI metrics, risk factors, and future outlook. It contains forward‐looking statement disclaimers and is formatted as an investor presentation rather than an official annual or interim financial report. There are no full financial statements, detailed certifications, or regulatory form references. Therefore, it best fits the “Investor Presentation” category.
2026-05-25 Japanese
資本準備金の額の減少及び剰余金の処分に関するお知らせ
Share Issue/Capital Change Classification · 99% confidence The document is an official Japanese exchange announcement from Renascience (ticker 4889) detailing a proposed reduction of capital reserve and appropriation of retained earnings under the Companies Act, including the amounts, legal basis (Articles 448 and 452), schedules (board resolution date, shareholder meeting date, effective date), and impact on balance sheet items. It is clearly an announcement of a capital structure change rather than a full report, dividend notice, or share buyback. This falls under 'Share Issue/Capital Change' (SHA) as 'other capital changes.'
2026-05-25 Japanese
局所進行非小細胞肺がんに対する第二相試験開始のお知らせ
Regulatory Filings
2026-04-24 Japanese
発行登録追補書類（株券､社債券等）
Capital/Financing Update Classification · 100% confidence The document is a 'Supplement to the Shelf Registration Statement' (発行登録追補書類) filed with the Tohoku Local Finance Bureau. It details the issuance of new stock acquisition rights (新株予約権証券) by Renascience Inc. to a specific investor (CVI Investments, Inc.) under an existing Equity Program Agreement. It includes specific terms of the issuance, use of proceeds, and legal disclosures required for securities offerings. This falls under the category of capital and financing updates.
2026-03-11 Japanese
発行登録追補書類（株券､社債券等）
Share Issue/Capital Change Classification · 95% confidence The document is a '発行登録追補書類' (Shelf Registration Supplement) filed with the Tohoku Local Finance Bureau by Renascience Inc. It details the issuance of new shares (third-party allotment) to CVI Investments, Inc. as part of an 'Equity Program Agreement'. This document provides specific terms of the share issuance, use of proceeds, and details regarding the counterparty. It is a formal regulatory filing related to capital raising and share issuance, which falls under the 'Share Issue/Capital Change' category.
2026-03-11 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.